BRD2 and Kallmann syndrome: Final clinical diagnosis was Kallmann syndrome (partial central hypogonadism, with a dissociated axis function showing a more affected LH-Leydig cell than FSH-Sertoli cells axis), and he was started again on testosterone enanthate 100 mg per month, with progressive increases up to 250 mg.